Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 27 June 2019. Rafael Carbunaru.

Executive Summary

New real-world clinical data support Boston Scientific's "all-in-one" spinal cord stimulation device for treating leg and lower-back pain. See what Rafael Carbunaru, VP for R&D in Boston Scientific's neuromodulation division said about it here.

“Each of these two mechanisms appear to be engaged through different primary neural targets in the spinal cord and are optimally activated with different stimulation waveforms and electrical dosing. We designed the Spectra WaveWriter system to optimize how we activate each of these two pathways, not only independently, but also simultaneously.” – Rafael Carbunaru, VP for R&D, Boston Scientific neuromodulation

Click here for a free trial of Medtech Insight

Advertisement

Related Content

Real-World Data Support Boston Scientific’s Personalized Spinal Cord Stimulation Therapy

Topics

Advertisement
UsernamePublicRestriction

Register

MT125296

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel